Literature DB >> 14718357

Modifier locus on mouse chromosome 3 for renal vascular pathology in AT1A receptor-deficiency.

Thu H Le1, Agnes B Fogo, Harmony R Salzler, Tania Vinogradova, Michael I Oliverio, Douglas A Marchuk, Thomas M Coffman.   

Abstract

We previously showed that the phenotype of mice with targeted disruption of the gene encoding the AT1A receptor (Agtr1a), the major murine AT1 receptor isoform, is strongly influenced by recessive genetic modifiers derived from the C57BL/6 or 129 inbred strains. To further evaluate the genetic modifiers on the C57BL/6 background, we performed backcrosses between F1(C57BL/6x129) and C57BL/6 Agtr1a-/- mice and analyzed the progeny, focusing on the development of structural lesions in the renal vasculature. In affected animals, these lesions are characterized by medial thickening of small arteries and arterioles in the kidney that are reminiscent of vascular lesions in patients with nephrosclerosis. Among 180 consecutive progeny, 170 (94%) survived to completion of the study. On masked pathological examination at age 8 months, 86 had intermediate to severe vascular lesions whereas 84 had no detectable lesions. Based on a hypothetical model of a single recessive modifier locus arising from the C57BL/6 background, the observed proportion of affected animals among the backcross progeny was not statistically different from that predicted by chi2 analysis (51% versus 50%; P=0.88). We next performed genomic microsatellite analysis in a subset of 121 backcross progeny using a panel of markers spanning approximately 15 cM intervals across the mouse genome. By 2-point analysis, we found a region spanning 5 cM on chromosome 3, with significant linkage to the development of renal vascular lesions (LOD score: 3.3 to 3.8).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718357     DOI: 10.1161/01.HYP.0000112423.28987.00

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  13 in total

1.  Gene expression profiles linked to AT1 angiotensin receptors in the kidney.

Authors:  Natalia A Makhanova; Steven D Crowley; Robert C Griffiths; Thomas M Coffman
Journal:  Physiol Genomics       Date:  2010-08-31       Impact factor: 3.107

2.  A role for angiotensin II type 1 receptors on bone marrow-derived cells in the pathogenesis of angiotensin II-dependent hypertension.

Authors:  Steven D Crowley; Young-Soo Song; Gregory Sprung; Robert Griffiths; Matthew Sparks; Ming Yan; James L Burchette; David N Howell; Eugene E Lin; Benson Okeiyi; Johannes Stegbauer; Yanqiang Yang; Pierre-Louis Tharaux; Phillip Ruiz
Journal:  Hypertension       Date:  2009-12-07       Impact factor: 10.190

3.  GSTM1 Deletion Exaggerates Kidney Injury in Experimental Mouse Models and Confers the Protective Effect of Cruciferous Vegetables in Mice and Humans.

Authors:  Joseph C Gigliotti; Adrienne Tin; Shirin Pourafshar; Sylvia Cechova; Yves T Wang; Sun-Sang J Sung; Gabor Bodonyi-Kovacs; Janet V Cross; Guang Yang; Nhu Nguyen; Fang Chan; Casey Rebholz; Bing Yu; Megan L Grove; Morgan E Grams; Anna Köttgen; Robert Scharpf; Phillip Ruiz; Eric Boerwinkle; Josef Coresh; Thu H Le
Journal:  J Am Soc Nephrol       Date:  2019-11-14       Impact factor: 10.121

4.  The Loss of GSTM1 Associates with Kidney Failure and Heart Failure.

Authors:  Adrienne Tin; Robert Scharpf; Michelle M Estrella; Bing Yu; Megan L Grove; Patricia P Chang; Kunihiro Matsushita; Anna Köttgen; Dan E Arking; Eric Boerwinkle; Thu H Le; Josef Coresh; Morgan E Grams
Journal:  J Am Soc Nephrol       Date:  2017-07-18       Impact factor: 10.121

5.  Sorting nexin 1 loss results in increased oxidative stress and hypertension.

Authors:  Jian Yang; Laureano D Asico; Amber L Beitelshees; Jun B Feranil; Xiaoyan Wang; John E Jones; Ines Armando; Santiago G Cuevas; Gary L Schwartz; John G Gums; Arlene B Chapman; Stephen T Turner; Eric Boerwinkle; Rhonda M Cooper-DeHoff; Julie A Johnson; Robin A Felder; Edward J Weinman; Chunyu Zeng; Pedro A Jose; Van Anthony M Villar
Journal:  FASEB J       Date:  2020-04-15       Impact factor: 5.191

6.  Cannabinoid receptor 1 is a major mediator of renal fibrosis.

Authors:  Lola Lecru; Christophe Desterke; Stanislas Grassin-Delyle; Christos Chatziantoniou; Sophie Vandermeersch; Aurore Devocelle; Amelia Vernochet; Ninoslav Ivanovski; Catherine Ledent; Sophie Ferlicot; Meriem Dalia; Myriam Saïd; Séverine Beaudreuil; Bernard Charpentier; Aimé Vazquez; Julien Giron-Michel; Bruno Azzarone; Antoine Durrbach; Hélène François
Journal:  Kidney Int       Date:  2015-03-11       Impact factor: 10.612

7.  Loss of GSTM1, a NRF2 target, is associated with accelerated progression of hypertensive kidney disease in the African American Study of Kidney Disease (AASK).

Authors:  Jamison Chang; Jennie Z Ma; Qing Zeng; Sylvia Cechova; Adam Gantz; Caroline Nievergelt; Daniel O'Connor; Michael Lipkowitz; Thu H Le
Journal:  Am J Physiol Renal Physiol       Date:  2012-12-05

8.  Hypertension and albuminuria in chronic kidney disease mapped to a mouse chromosome 11 locus.

Authors:  H R Salzler; R Griffiths; P Ruiz; L Chi; C Frey; D A Marchuk; H A Rockman; T H Le
Journal:  Kidney Int       Date:  2007-09-12       Impact factor: 10.612

9.  Glutathione S-transferase-micro1 regulates vascular smooth muscle cell proliferation, migration, and oxidative stress.

Authors:  Yanqiang Yang; Kelly K Parsons; Liqun Chi; Sandra M Malakauskas; Thu H Le
Journal:  Hypertension       Date:  2009-10-12       Impact factor: 10.190

10.  The impact of microsomal prostaglandin e synthase 1 on blood pressure is determined by genetic background.

Authors:  Carie S Facemire; Robert Griffiths; Laurent P Audoly; Beverly H Koller; Thomas M Coffman
Journal:  Hypertension       Date:  2010-01-11       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.